A Study to Determine if Technosphere® Inhalation Powder (FDKP) Causes ECG Changes (QTc) Following the Medication's Inhaled Administration.

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

October 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

Technosphere Inhalation Powder (FDKP)

Technosphere® Inhalation Powder 20mg

DRUG

Moxifloxacin

Tablets 400mg

DRUG

Technosphere Inhalation Powder (FDKP)

Technosphere® Inhalation Powder 40mg

DRUG

Placebo

Placebo cartridges

Trial Locations (1)

Charles River Clinical Services Northwest, Tacoma